Ginovart Nathalie, Wilson Alan A, Hussey Doug, Houle Sylvain, Kapur Shitij
The Vivian Rakoff Positron Emission Tomography Unit, Centre for Addiction and Mental Health and University of Toronto, Toronto, ON, Canada.
Neuropsychopharmacology. 2009 Feb;34(3):662-71. doi: 10.1038/npp.2008.116. Epub 2008 Aug 6.
Long-term occupancy of dopamine D(2)-receptors, as achieved by chronic treatment with antipsychotics, leads to D(2)-receptor upregulation, and this upregulation is thought to be responsible for loss of efficacy and development of tardive dyskinesia. However, little is known about the parameters of D(2)-receptor blockade (duration and percentage of blockade) that lead to upregulation. In this study, we investigated the effects of different degrees (60 vs >80%) and durations (a transient peak vs 24 h/day) of D(2)-receptor blockade on inducing this upregulation. These different patterns of D(2)-receptor occupancy kinetics were produced in cats using bolus vs constant infusion of haloperidol for 4 weeks. D(2)-receptors were measured using positron emission tomography and Scatchard analyses of [(11)C]raclopride binding, before and after withdrawal of treatment. Continuously high (80% for 24 h/day) D(2)-receptor blockade led to a robust upregulation of striatal D(2)-receptors that was maximal at 1-week withdrawal (35+/-5%) and still detectable at 2-week withdrawal (20+/-3%). This pattern of D(2)-receptor blockade also induced behavioral tolerance to the effect of haloperidol on spontaneous locomotor activity. Continuously moderate (60% for 24 h/day) or transiently high (80% for a few hours/day) D(2)-receptor blockade did not produce any of these effects. The long-term effect of haloperidol on D(2)-receptor density and behavioral tolerance thus appears to be dependent not only on a critical threshold of D(2)-receptor blockade but also on the daily duration of D(2)-receptors blockade. This suggests that as far as antipsychotics are concerned, not only dose but disbursment throughout the day have an impact on eventual pharmacodynamic and behavioral outcomes.
通过使用抗精神病药物进行长期治疗所实现的多巴胺D(2)受体的长期占据,会导致D(2)受体上调,并且这种上调被认为是导致疗效丧失和迟发性运动障碍发生的原因。然而,关于导致上调的D(2)受体阻断参数(阻断持续时间和阻断百分比)却知之甚少。在本研究中,我们调查了不同程度(60%对>80%)和持续时间(短暂峰值对每天24小时)的D(2)受体阻断对诱导这种上调的影响。使用氟哌啶醇推注与持续输注4周在猫中产生了这些不同模式的D(2)受体占据动力学。在治疗撤药前后,使用正电子发射断层扫描和对[(11)C]雷氯必利结合进行Scatchard分析来测量D(2)受体。持续高水平(每天24小时为80%)的D(2)受体阻断导致纹状体D(2)受体的强烈上调,在撤药1周时达到最大值(35±5%),在撤药2周时仍可检测到(20±3%)。这种D(2)受体阻断模式还诱导了对氟哌啶醇对自发运动活动影响的行为耐受性。持续中等水平(每天24小时为60%)或短暂高水平(每天几小时为80%)的D(2)受体阻断未产生任何这些效应。因此,氟哌啶醇对D(2)受体密度和行为耐受性的长期影响似乎不仅取决于D(2)受体阻断的临界阈值,还取决于D(2)受体阻断的每日持续时间。这表明就抗精神病药物而言,不仅剂量而且全天的给药分布都会对最终的药效学和行为结果产生影响。